VeriMom¿Es lavandula angustifolia callus extract seguro durante el embarazo?
No EU Annex II/III listing for reproductive restriction or ban for Lavandula angustifolia callus extract, no harmonised CLP reproductive (H360/H361) or mutagenic/carcinogenic classification found, and no animal or human reproductive/developmental toxicity data identified for the callus extract in PubMed or regulatory dossiers. Available safety literature and CosIng list the ingredient as a cosmetic extract/INCI entry and recent peer‑reviewed work on the callus extract reports skin-recovery/Nrf2 activity, not reproductive effects (ECHA substance pages; CosIng/Official Journal; PubMed). ([echa.europa.eu](https://www.echa.europa.eu/substance-information/-/substanceinfo/100.081.783?utm_source=openai))
Related ingredients
Frequently asked questions
- ¿Es lavandula angustifolia callus extract seguro durante el embarazo?
- No EU Annex II/III listing for reproductive restriction or ban for Lavandula angustifolia callus extract, no harmonised CLP reproductive (H360/H361) or mutagenic/carcinogenic classification found, and no animal or human reproductive/developmental toxicity data identified for the callus extract in PubMed or regulatory dossiers. Available safety literature and CosIng list the ingredient as a cosmetic extract/INCI entry and recent peer‑reviewed work on the callus extract reports skin-recovery/Nrf2 activity, not reproductive effects (ECHA substance pages; CosIng/Official Journal; PubMed). ([echa.europa.eu](https://www.echa.europa.eu/substance-information/-/substanceinfo/100.081.783?utm_source=openai))
- ¿Es lavandula angustifolia callus extract seguro durante la lactancia?
- Same evidence base as for pregnancy: no harmonised reproductive or lactation hazards, no SCCS/CIR reproductive concerns located for this specific callus extract, and no published data showing placental or milk transfer for the callus extract. Ingredient is treated in regulatory databases as a botanical extract without reproductive classification. ([echa.europa.eu](https://www.echa.europa.eu/substance-information/-/substanceinfo/100.081.783?utm_source=openai))
- ¿Es lavandula angustifolia callus extract seguro para la piel del bebé?
- Hazard and mechanism: no specific infant reproductive or developmental hazards identified for this callus extract. Exposure: topical botanical extracts commonly contain small lipophilic constituents (e.g., linalool/linalyl acetate reported for L. angustifolia essential oil) that are dermally bioavailable to a low degree in adults; infant skin has higher absorption — therefore adult exposure scored as low/measurable and infant exposure increased by +1 per instructions (adult e=1 → baby e=2). CosIng/ECHA list the extract as a cosmetic ingredient; EWG/EU allergen lists note allergenic constituents of lavender but not reproductive effects. ([boe.es](https://www.boe.es/doue/2019/121/L00001-00370.pdf?utm_source=openai))
- ¿Cómo puntúa VeriMom a lavandula angustifolia callus extract?
- VeriMom puntúa lavandula angustifolia callus extract en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a lavandula angustifolia callus extract en el embarazo?
- Consulta nuestra lista de alternativas seguras a lavandula angustifolia callus extract según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.